The Uromigos
Autor: The Uromigos
Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London
Odcinki
- Episode 523: ESMO 2026: ctDNA Kinetics from Neoadjuvant EVP in MIBC – The Uromigos
- Episode 522: ESMO 2026 - KEYNOTE-905 Analysis of Neoadjuvant EVP or Pembro Monotherapy in Cis-ineligible MIBC – The Uromigos
- Episode 521: ESMO 2026 - Reconciling Discrepant Results of Neoadjuvant Chemotherapy + IO in MIBC – The Uromigos
- Episode 520: ESMO 2026 Preview – The Uromigos
- Episode 519: What is the Appropriate Approach to Adjuvant Therapy for UTUC? – The Uromigos
- Episode 518: PSMAddition in Clinical Practice – The Uromigos
- Episode 517: Casdatifan Clinical Data in RCC and Translational Correlates – The Uromigos
- Episode 516: The Influence of Hypoxia on Response and Resistance in RCC – The Uromigos
- Episode 515: PROTEUS - A Reflection on the Data and Controversies with Neha Vapiwala – The Uromigos
- Episode 514: Artificial Intelligence in Cancer Drug Development – The Uromigos
- Episode 513: Trials and Tribulations of Investigator-initiated Research – The Uromigos
- Episode 512: ENZA-P Nature Medicine translational data – The Uromigos
- Episode 510: ADCs in Prostate Cancer – The Uromigos
- Episode 509: ASCO 2026 Review – The Uromigos
- Episode 508: ASCO 2026 Plenary - PROTEUS: ADT +/- Apalutamide in high-risk Localized Prostate Cancer – The Uromigos
- Episode 507: ASCO 2026 - TALAPRO-3 – The Uromigos
- Episode 506: ASCO 2026 - How do we measure quality of life in GU patients? – The Uromigos
- Episode 505 : ASCO 2026 - RAMPART – The Uromigos
- Episode 504: ASCO 2026 - ADC Drug Development in Urothelial Cancer – The Uromigos
- Episode 499: APCCC 2026 - Radioligands in Prostate Cancer – The Uromigos
- Episode 503: ASCO 2026 Preview – The Uromigos
- Episode 502: AUA 2026 and FDA bladder cancer meeting – The Uromigos
- Episode 501: APCCC 2026 - Biochemically-relapsed Prostate cancer – The Uromigos
- Episode 500: RAS Inhibition in Pancreatic Cancer (yes this is the Uromigos podcast..) – The Uromigos
- Episode 499: APCCC 2026 - Radioligands – The Uromigos
- Episode 498: APCCC 2026 - mCRPC – The Uromigos
- Episode 497: Reflections on the capivasertib ODAC – The Uromigos
- Episode 496: APCCC 2026 - mHSPC Landscape – The Uromigos
- Episode 495: APCCC 2026 - Locally-advanced Prostate Cancer – The Uromigos
- Episode 494: Duration of EVP in Multiple Urothelial Cancer Settings / Paper of the Month PPARG Inverse Agonist – The Uromigos